Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Maria Lucia Rosa Rossetti is active.

Publication


Featured researches published by Maria Lucia Rosa Rossetti.


Journal of Clinical Microbiology | 2003

Mutations in katG, inhA, and ahpC Genes of Brazilian Isoniazid-Resistant Isolates of Mycobacterium tuberculosis

Márcia Susana Nunes Silva; Simone Gonçalves Senna; Marta Osório Ribeiro; Andréia Rosane de Moura Valim; Maria Alice da Silva Telles; Afrânio Lineu Kritski; Glenn P. Morlock; Robert C. Cooksey; Arnaldo Zaha; Maria Lucia Rosa Rossetti

ABSTRACT The presence of mutations in specific regions of the katG, inhA, and ahpC genes was analyzed with 69 Mycobacterium tuberculosis isoniazid-resistant isolates from three Brazilian states. Point mutations in codon 315 of the katG gene were observed in 87.1, 60.9, and 60% of the isolates from Rio Grande do Sul, Rio de Janeiro, and São Paulo, respectively. Mutations in the inhA gene were identified only in one isolate from RJ State, and the ahpC promoter region revealed mutations in distinct positions in 12.9, 21.7, and 6.7% of the isolates from RS, RJ and SP, respectively.


European Journal of Clinical Pharmacology | 2008

Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil

Lia Gonçalves Possuelo; J. A. Castelan; T. C. de Brito; Andrezza Wolowski Ribeiro; Patrícia Izquierdo Cafrune; P. D. Picon; Adalberto R. Santos; Raquel Lima de Figueiredo Teixeira; Tatiana Schäffer Gregianini; Mara H. Hutz; Maria Lucia Rosa Rossetti; Arnaldo Zaha

PurposeTo determine the frequency of N-acetyltransferase 2 (NAT2) polymorphisms, the NAT2 acetylation profile and its relation to the incidence of gastrointestinal adverse drug reactions (ADRs), anti-tuberculosis (TB) drug-induced hepatotoxicity, and the clinical risk factors for hepatotoxicity in a population from Brazil.MethodsTwo hundred and fifty-four Brazilian TB patients using isoniazid (INH), rifampicin (RMP), and pirazinamide (PZA) were tested in a prospective cohort study. NAT2 genotyping was performed by direct PCR sequencing. The association between gastrointestinal ADRs/hepatotoxicity and the NAT2 profile genotype was evaluated by univariate analysis and multiple logistic regression.ResultsOf the 254 patients analyzed, 69 (27.2%) were slow acetylators and 185 (72.8%) were fast acetylators. Sixty-five (25.6%) patients were human immunodeficiency virus (HIV)-positive. Thirty-three (13%) and 14 (5.5%) patients developed gastrointestinal ADR and hepatotoxicity, respectively. Of the 14 hepatotoxicity patients, nine (64.3%) were slow acetylators and five (35.7%) were fast acetylators. Sex, age, presence of hepatitis C virus, alcohol abuse, and baseline aminotransferases were not found to be risk factors for hepatotoxicity. However, logistic regression analysis revealed that slow acetylator status and the presence of HIV (p < 0.05) were independent risk factors for hepatotoxicity.ConclusionsOur findings show that HIV-positive patients that have the slow acetylation profile are significantly associated with a higher risk of developing hepatotoxicity due to anti-TB drugs.


BMC Microbiology | 2009

Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.

Elis Regina Dalla Costa; Marta Osório Ribeiro; Márcia Susana Nunes Silva; Liane Silveira Arnold; Diana Rostirolla; Patrícia Izquierdo Cafrune; Roger Espinoza; Moises Palaci; Maria Alice da Silva Telles; Viviana Ritacco; Philip Noel Suffys; Maria Luiza Lopes; Creuza Campelo; Silvana Spindola de Miranda; Kristin Kremer; Pedro Eduardo Almeida da Silva; Leila de Souza Fonseca; John L. Ho; Afranio Lineu Kritski; Maria Lucia Rosa Rossetti

BackgroundMutations associated with resistance to rifampin or streptomycin have been reported for W/Beijing and Latin American Mediterranean (LAM) strain families of Mycobacterium tuberculosis. A few studies with limited sample sizes have separately evaluated mutations in katG, ahpC and inhA genes that are associated with isoniazid (INH) resistance. Increasing prevalence of INH resistance, especially in high tuberculosis (TB) prevalent countries is worsening the burden of TB control programs, since similar transmission rates are noted for INH susceptible and resistant M. tuberculosis strains.ResultsWe, therefore, conducted a comprehensive evaluation of INH resistant M. tuberculosis strains (n = 224) from three South American countries with high burden of drug resistant TB to characterize mutations in katG, ahpC and inhA gene loci and correlate with minimal inhibitory concentrations (MIC) levels and spoligotype strain family. Mutations in katG were observed in 181 (80.8%) of the isolates of which 178 (98.3%) was contributed by the katG S315T mutation. Additional mutations seen included oxyR-ahpC; inhA regulatory region and inhA structural gene. The S315T katG mutation was significantly more likely to be associated with MIC for INH ≥2 μg/mL. The S315T katG mutation was also more frequent in Haarlem family strains than LAM (n = 81) and T strain families.ConclusionOur data suggests that genetic screening for the S315T katG mutation may provide rapid information for anti-TB regimen selection, epidemiological monitoring of INH resistance and, possibly, to track transmission of INH resistant strains.


Antimicrobial Agents and Chemotherapy | 2008

Identification of Mutations Related to Streptomycin Resistance in Clinical Isolates of Mycobacterium tuberculosis and Possible Involvement of Efflux Mechanism

Fernanda Sá Spies; Pedro Eduardo Almeida da Silva; Marta Osório Ribeiro; Maria Lucia Rosa Rossetti; Arnaldo Zaha

ABSTRACT The MIC for streptomycin in the presence of efflux pump (EP) inhibitors and the sequencing of rpsL, rrs, and gidB genes provided evidence for the possible participation of EP in low-level streptomycin (STR) resistance of some isolates without mutations. Mutation in the gidB gene and an EP could act synergistically to confer low STR resistance.


Memorias Do Instituto Oswaldo Cruz | 2008

Mycobacterium tuberculosis strains of the Beijing genotype are rarely observed in tuberculosis patients in South America

Viviana Ritacco; Patrícia Izquierdo Cafrune; Lucilaine Ferrazoli; Philip Noel Suffys; Norma Candia; Lucy Vásquez; Teresa Realpe; Jorge Fernández; Karla Valéria Batista Lima; Jeannete Zurita; Jaime Robledo; Maria Lucia Rosa Rossetti; Afranio Lineu Kritski; Maria Alice da Silva Telles; Juan Carlos Palomino; Herre Heersma; Dick van Soolingen; Kristin Kremer; Lucía Barrera

The frequency of the Beijing genotype of Mycobacterium tuberculosis as a cause of tuberculosis (TB) in South America was determined by analyzing genotypes of strains isolated from patients that had been diagnosed with the disease between 1997 and 2003 in seven countries of the subcontinent. In total, 19 of the 1,202 (1.6%) TB cases carried Beijing isolates, including 11 of the 185 patients from Peru (5.9%), five of the 512 patients from Argentina (1.0%), two of the 252 Brazilian cases (0.8%), one of the 166 patients from Paraguay (0.6%) and none of the samples obtained from Chile (35), Colombia (36) and Ecuador (16). Except for two patients that were East Asian immigrants, all cases with Beijing strains were native South Americans. No association was found between carrying a strain with the Beijing genotype and having drug or multi-drug resistant disease. Our data show that presently transmission of M. tuberculosis strains of the Beijing genotype is not frequent in Latin America. In addition, the lack of association of drug resistant TB and infection with M. tuberculosis of the Beijing genotype observed presently demands efforts to define better the contribution of the virulence and lack of response to treatment to the growing spread of Beijing strains observed in other parts of the world.


Infection, Genetics and Evolution | 2012

Spoligotypes of Mycobacterium tuberculosis complex isolates from patients residents of 11 states of Brazil

Harrison Magdinier Gomes; Atina Ribeiro Elias; Maranibia Aparecida Cardoso Oelemann; Marcia Aparecida da Silva Pereira; Fátima Fandinho Onofre Montes; Ana Grazia Marsico; Afrânio Lineu Kritski; Luciano dos Anjos Filho; Paulo Cesar de Souza Caldas; Lia Gonçalves Possuelo; Patrícia Izquierdo Cafrune; Maria Lucia Rosa Rossetti; Norma Lucena; Maria Helena Féres Saad; Hebe Rodrigues Cavalcanti; Clarisse Queico Fujimura Leite; Rossana Coimbra Brito; Maria Luiza Lopes; Karla Valéria Batista Lima; Maisa Souza; Rita de Cássia Trindade; Thierry Zozio; Christophe Sola; Nalin Rastogi; Philip Noel Suffys

One of the high tuberculosis (TB) incidence countries in the world, Brazil is characterized by considerable differences in TB incidence on regional and state level. In the present study, we describe Brazilian spoligotypes of 1991 Mycobacterium tuberculosis complex (MTC) clinical isolates from patients residents of 11 states from different regions of the country, diagnosed between 1996 and 2005. By performing spoligotyping on a large number of M. tuberculosis clinical isolates, one of the main objectives of this study was to determine the major genotype families causing TB in Brazil and to verify the region-associated genotype distribution. We observed a total of 577 distinct spoligopatterns, 12.6% of these corresponded to orphan patterns while 87.4% belonged to 326 shared-types (SITs). Among the latter, 86 SITs (isolated from 178 patients) had been observed for the first time in this study, the most frequent being SIT2517 which belonged to the T3-ETH lineage and was exclusively found among patients residents of Belém, the capital of the state of Pará (n=8 isolates). Irrespective of shared-type labeling, a total of 19.5% strains were unique (unclustered) in our study as opposed to 80.5% clustered isolates (189 clusters, size range from 2 to 205 isolates). The three largest clusters were SIT42 of the Latin-America & Mediterranean (LAM) 9 clade (10.3%), SIT53 of the T clade (7.6%), and SIT50 of the Haarlem clade (5.4%). The predominant MTC lineages in Brazil in decreasing order belonged to the LAM (46%); the ill-defined T (18.6%); the Haarlem (12.2%), the X (4.7%), the S (1.9%), and the East African Indian (EAI) (0.85%) families. The rest of clades grouped together as Mycobacterium africanum, Mycobacterium bovis, Beijing, Central Asian (CAS), and the Manu types, represented less than 1% of the strains. Finally, about 15% of the isolates showed spoligotype signatures that were not yet classified among well-defined lineages. In conclusion, we provide hereby a first insight into the population structure of MTC isolates in Brazil, showing the predominance of both LAM and T family and the existence of region-associated genotypes.


Revista De Saude Publica | 2002

Tuberculose resistente: revisão molecular

Maria Lucia Rosa Rossetti; Andréia Rosane de Moura Valim; Márcia Susana Nunes Silva; Vívian de F.S. Rodrigues

Progress to understanding the basis of resistance to antituberculous drugs has allowed molecular tests for detection of drug-resistant tuberculosis to be developed. Drug-resistant tuberculosis poses a threat to tuberculosis control programs. It is necessary thus to know drug susceptibilities of individual patients strain to provide the appropriate drug combinations. Molecular studies on the mechanism of action of antituberculous drugs have elucidated the genetic basis of drug resistance in M. tuberculosis. The mechanisms of drug resistance in tuberculosis are a result of chromosomal mutations in different genes of the bacteria. Upon drug exposure there is a selective pressure for such resistant mutants. Multidrug-resistant tuberculosis is a health problem of increasing significance for the whole global community. This paper reviews the molecular mechanisms associated with drug-resistance as well the new perspectives for detecting resistant isolates.


Journal of Infection | 2008

High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil

Luciana Weidlich; Ludmila Fiorenzano Baethgen; Leonard W. Mayer; Camile Moraes; Cecília Coimbra Klein; Luciana de Souza Nunes; Sílvia Rios; Claudete Iris Kmetzsch; Maria Lucia Rosa Rossetti; Arnaldo Zaha

OBJECTIVES The aim of this study was to characterize Neisseria meningitidis strains causing invasive disease in Rio Grande do Sul (RS), during 2003-2005, monitoring the occurrence of hypervirulent lineages, as well as to determine the diversity of PorA VR types for the corresponding isolates and clinical specimens. METHODS Isolates and clinical specimens were characterized by MLST and PorA VR typing. RESULTS This study demonstrated high prevalence of some hypervirulent lineages and emergence of new ones, including the emergence of lineages W135:P1.5,2:ST-11 complex, and C:P1.22,14-6:ST-103 complex. These lineages are probably responsible for the increasing incidence of serogroups C and W135, despite the overall decrease in serogroup B cases during the period. The most prevalent complex was serogroup B ST-32/ET-5 complex. The most prevalent PorA types found for serogroup B were P1.19,15, P1.7,16, and P1.18-1,3, representing a different distribution of PorA types compared to other states of Brazil. CONCLUSIONS This study highlights the importance of monitoring each population, even within the same country. The different distribution of PorA VR types in RS has implications in vaccine design and efficacy. Detailed and accurate meningococcal characterization is an important element in studies of meningococcal epidemiology, population biology, and evolution and provides information for the design of control strategies.


Journal of Clinical Microbiology | 2011

Streptomycin resistance and lineage specific polymorphisms in Mycobacterium tuberculosis gidB gene

Fernanda Sá Spies; Andrezza Wolowski Ribeiro; Daniela Fernandes Ramos; Marta Osório Ribeiro; Anandi Martin; Juan Carlos Palomino; Maria Lucia Rosa Rossetti; Pedro Eduardo Almeida da Silva; Arnaldo Zaha

ABSTRACT Mutations related to streptomycin resistance in the rpsL and rrs genes are well known and can explain about 70% of this phenotypic resistance. Recently, the gidB gene was found to be associated with low-level streptomycin resistance in Mycobacterium tuberculosis. Mutations in gidB have been reported with high frequency, and this gene appears to be very polymorphic, with frameshift and point mutations occurring in streptomycin-susceptible and streptomycin-resistant strains. In this study, mutations in gidB appeared in 27% of streptomycin-resistant strains that contained no mutations in the rpsL or rrs genes, and they were associated with low-level streptomycin resistance. However, the association of certain mutations in gidB with streptomycin resistance needs to be further investigated, as we also found mutations in gidB in streptomycin-susceptible strains. This occurred only when the strain was resistant to rifampin and isoniazid. Two specific mutations appeared very frequently in this and other studies of streptomycin-susceptible and -resistant strains; these mutations were not considered related to streptomycin resistance, but as a polymorphism. We stratified the strains according to the different phylogenetic lineages and showed that the gidB 16 polymorphism (16G allele) was exclusively present in the Latin American-Mediterranean (LAM) genotype, while the gidB 92 polymorphism (92C allele) was associated with the Beijing lineage in another population. In the sample studied, the two characterized single-nucleotide polymorphisms could distinguish LAM and Beijing lineages from the other lineages.


Antimicrobial Agents and Chemotherapy | 2005

Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis in Brazil

Vívian de F.S. Rodrigues; Maria Alice da Silva Telles; Marta Osório Ribeiro; Patrícia Izquierdo Cafrune; Maria Lucia Rosa Rossetti; Arnaldo Zaha

ABSTRACT In this study the nucleotide sequence of the pncA gene from 59 Mycobacterium tuberculosis clinical isolates was analyzed. Mutations in the pncA gene were identified in 29 of 40 pyrazinamide-resistant isolates, and no pyrazinamidase activity was detected in 39 of them. Twelve mutations found in this work have not been described previously.

Collaboration


Dive into the Maria Lucia Rosa Rossetti's collaboration.

Top Co-Authors

Avatar

Arnaldo Zaha

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marta Osório Ribeiro

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Elis Regina Dalla Costa

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Regina Bones Barcellos

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar

Rosa Dea Sperhacke

Federal University of Rio de Janeiro

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cláudia Maria Dornelles da Silva

Universidade Federal do Rio Grande do Sul

View shared research outputs
Top Co-Authors

Avatar

Graziele Lima Bello

Universidade Luterana do Brasil

View shared research outputs
Top Co-Authors

Avatar

Patrícia Izquierdo Cafrune

Universidade Federal do Rio Grande do Sul

View shared research outputs
Researchain Logo
Decentralizing Knowledge